Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1, Multicenter, Open-Label, Safety and Pharmacokinetic Study of Orally Administered Ivosidenib in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment
The objective of this study is to investigate the PK, PD, safety, and tolerability of ivosidenib in adult participants with IDH1-mutated malignancies and hepat…
IDH1-Mutated Malignancies
Servier Bio-Innovation LLCNCT07006688
Phase 2
Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations
To learn about the safety and tolerability of study drug combinations in patients with relapsed/refractory, IDH1-mutated myeloid malignancies with a co-signali…
Targeted TherapyIDH1-Mutated MalignanciesMutations
M.D. Anderson Cancer CenterNCT07032727